Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma
Romanos Sklavenitis‐Pistofidis, Michelle P. Aranha, Robert Redd, Joanna Bagińska, Nicholas J. Haradhvala, Margaret Hallisey, Ankit K. Dutta, Alexandra Savell, Shohreh Varmeh, Daniel Heilpern-Mallory, Sylvia Ujwary, Oksana Zavidij, François Aguet, Nang Kham Su, Elizabeth D. Lightbody, Mark Bustoros, Sabrin Tahri, Tarek H. Mouhieddine, Ting Wu, Lea Flechon, Shankara Anand, Jacalyn Rosenblatt, Jeffrey A. Zonder, James J. Vredenburgh, Adam Boruchov, Manisha Bhutani, Saad Z. Usmani, Jeffrey Matous, Andrew J. Yee, Andrzej Jakubowiak, Jacob P. Laubach, Salomon Manier, Omar Nadeem, Paul G. Richardson, Ashraf Badros, María‐Victoria Mateos, Lorenzo Trippa, Gad Getz, Irene M. Ghobrial
Topics & Concepts
Immune systemLenalidomideGranzymeImmunotherapyMultiple myelomaBone marrowCD8ImmunologyT-cell receptorDaratumumabBiologyT cellMedicineCancer researchPerforinMultiple Myeloma Research and TreatmentsT-cell and B-cell ImmunologyImmunotherapy and Immune Responses